CRA II

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We are a global provider of consulting and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organizations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality. Our global team of experts has extensive experience in a broad range of therapeutic areas.

We are proud to have developed 18 of the world's top 20 best-selling drugs, showcasing our commitment to driving advancements in the healthcare sector. Our extensive portfolio of services includes early clinical and bioanalytical solutions, specialty laboratory solutions, cardiac safety solutions, and many more. Additionally, we emphasize patient-centric trial design and real-world data strategies to optimize recruitment and ensure the success of clinical trials. Through these innovations, ICON is not only enhancing clinical research methodologies but also transforming the overall experience for sponsors, patients, and healthcare providers alike.